Diagnostics

BotrytisAlert is a low-cost test which can be used to measure the fungal crop pathogen Botrytis both in air and plant material, enabling growers to apply controlled measures ahead of symptom development

These 10 antibodies recognize different epitopes of the SARS-CoV-2 Spike glycoprotein, nine of which are SARS-CoV-2-specific and do not cross-react with other human coronaviruses

New technology allows anyone to easily and quickly diagnose COVID-19 based on the RNA sequence of the virus 

A crucial part of the global effort to stem the spread of the pandemic is the development of tests that can rapidly identify infections in asymptomatic people

The Access Interleukin-6 (IL-6) assay is designed to assist physicians in the identification of severe inflammatory response in COVID-19 patients

SARS-CoV-2 Assay for BD Veritor™ Plus System to be available in Europe by end of October

A multisite clinical trial provides the first evidence that both devices are comparable for accurate detection of COVID-19 infection

A CRISPR-based test developed at MIT and the Broad Institute can detect nearly as many cases as the standard COVID-19 diagnostic

The tests provide significantly higher sensitivity than currently available COVID-19 tests

This COVID-19 diagnostic tool will validate serological testing for antibodies, helping to fight against the disease